This program funds the transition phase of Alzheimer's disease and related dementias research initiatives built on NIH cooperative awards. It supports scientific continuity, study operations, and diversification planning to sustain research teams and activities through funding gaps or scale adjustments. Awards range from $200,000 to $1,000,000 for up to 12 months, with no indirect costs allowed. Applicants must be associated with specific NIH awards and submit a required pre-submission query by Dec 15, 2026.
Applicants must be associated with an active or recently lapsed NIH U01, U19, U24, or U54 award supporting major AD/ADRD research. No restriction on career stage. Government-appropriated labs (except VA hospitals) are ineligible.
